MedWatch

WSA raises guidance in first-ever public H1 report

Hearing aid company WS Audiology upgrades its guidance for revenue and operating results after a great sales half-year. WSA does not disclose its bottom line, which has shown a considerable deficit in the last two financial reports.

Photo: Tidsvilde Stine/Ritzau Scanpix

The world's third-largest hearing aid manufacturer, WS Audiology, has had the wind in its sales in the six first months of its financial year spanning from Oct. 1 2020 to March 31 2021.

The firm usually only presents its fiscal report once every year, but as a new feature, the company has now presented the accounting figures after the first half-year.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs